Product information
| Price | €175, €275, €395 |
|---|---|
| Size | 20 µl/µg | 50 µl/µg | 100 µl/µg |
| Short name | Chromodomain-helicase-DNA-binding protein 9 |
| Host | Rabbit |
| Isotype | IgG |
| Target protein | CHD9 |
| Recommended applications | IF, IHC-p |
| Reactivity | Human, Mouse |
| Immunogen | Synthesized peptide derived from part region of human protein |
| Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Formulation | Liquid in PBS containing 50% glycerol; and 0.02% sodium azide. |
| Storage | -20°C for 1 year |
| Product code | MB-AP12942 |
Additional information
Prev
Next
Acts as a transcriptional coactivator for PPARA and possibly other nuclear receptors. Proposed to be a ATP-dependent chromatin remodeling protein. Has DNA-dependent ATPase activity and binds to A/T-rich DNA. Associates with A/T-rich regulatory regions in promoters of genes that participate in the differentiation of progenitors during osteogenesis.,PTM:Phosphorylated on serine and tyrosine residues.,sequence Wrong choice of frame.,Belongs to the SNF2/RAD54 helicase family.,Contains 1 helicase ATP-binding domain.,Contains 1 helicase C-terminal domain.,Contains 2 chromo domains.,subunit:Interacts with PPARA. Probably interacts with ESR1 and NR1I3.,tissue specificity:Widely expressed at low levels. In bone marrow, expression is restricted to osteoprogenitor cells adjacent to mature osteoblasts.,
Chromodomain-helicase-DNA-binding protein 9 ,CHD-9,EC 3.6.4.12,ATP-dependent helicase CHD9,Chromatin-related mesenchymal modulator,CReMM,Chromatin-remodeling factor CHROM1,Kismet homolog 2
Human: Q3L8U1, Mouse: Q8BYH8
Human: 80205
